International Journal of Medical Sciences

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Leptospirosis:A Disease of Public Health Importance


Affiliations
1 Department of Foods and Nutrition, Ethelind School of Home Science, Sam Higginbottom Institute of Agriculture, Technology and Sciences, ALLAHABAD (U.P.), India
2 Department of Foods and Nutrition, Ethelind School of Home Science, Sam Higginbottom Institute of Agriculture, Technology and Sciences, ALLAHABAD (U.P.), India
     

   Subscribe/Renew Journal


Leptospirosis has been recognized as an important emerging global public health problem because of its epidemic proportions and increasing incidence in both developing and developed countries. The disease is endemic in Kerala, Tamil Nadu, Gujarat, Andaman, Karnataka, Maharashtra. It has also been reported from Andhra Pradesh, Orissa, West Bengal, Uttar Pradesh, Delhi and Puducherry. It is an infectious disease caused by pathogenic bacteria called leptospires which has over 20 serogroups and more than 200 serovars. Man is infected either directly through contact with an infected animal or indirectly by water or soil contaminated with the urine of an infected animal. Human-to-human transmission occurs only very rarely. Leptospirosis can manifest in many ways. Clinical diagnosis is difficult because of the varied and non-specific presentation. In this situation, ELISA tests is particularly useful in making early diagnosis. Other serological tests available are indirect flouroscent antibody test (IFAT), indirect hemagglutination tests (IHAT), latex agglutination tests (LAT), micro capsule agglutination tests (MicAT), counter immuneelectrophoresis (CIE) and CFT etc. Antibiotic treatment is effective within 7 to 10 days of infection and it should be given immediately on diagnosis or suspicion. In severe cases, admission to a hospital is necessary. Identification of the potential risk factors would help understand the transmission dynamics of the disease and formulate public health interventions.

Keywords

Leptospirosis, Outbreak, Clinical Diagnosis, Risk Factors.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Andersson, L. (2009). Leptospirosis- the neglected disease: Clinical picture and epidemiology at the Andman Islands India, 12p.

  • Berger, S. (2015). Leptospirosis: Global Status. Google Books. By GIDEON Informatics, Inc.

  • Clapham, D. (2004). Small water supplies : A Practical Guide. Routledge, p. 125. ISBN 9781134457496.

  • Clerke, A. M., Leuva, A.C., Joshi, C. and Trivedi, S.V. (2002). Clinical profile of leptospirosis in south Gujarat. J Post Grad. Med., 48 : 117-118.

  • Das Gupta, B.M. (1938). Leptospirosis in India. Indian Med. Gaz., 73:449-53.

  • Das Gupta, B.M. and Chopra, R.N. (1937). The occurrence of Weil’s disease in Indian. Indian Med. Gaz., 72 :610-612.

  • Deodhar, D. and John, M. (2011). Leptospirosis: Experience at a tertiary care hospital in northern India. Nat. Med. J. Indian, 24 (2): 78-80.

  • Dutta, T. K., Parija, S.C. and Dutta, J.K. (2012). Emerging and Re-Emerging Infectious Diseases, 70-71pp.

  • Edward, A., Hodder and Staughton (1990). Leptospirosis. Quoted in Topley and Wilson’s Principles of Bacteriology, Virology & Immunity. 8 (3) : 619.

  • Faine, S. (1982). Guidelines for the control of Leptospirosis. WHO offset Publication, 67.

  • Faine, S. (1994). Leptospira and Leptospirosis. CRC Press, Boca Raton, FLORIDA, USA.

  • Faine, S., Adler, B., Bolin, C. and Perolat, P. (1999). Leptospira and Leptospirosis. Second Edition.

  • Ghulani, K.K. (2008). Community health nursing. 1st Ed., Kumar Publishing house, p.290, NEW DELHI, INDIA.

  • Goldman, L. and Ausiello, D. (2007). Leptosiposis. Cecil medicine. 23rd Eds. Philadelphia, Pa: Saunders Elsevier, Chapter 344.

  • Inada, R., Ido, Y., Hoki, R., Kaneko, R. and Ito, H. (1916). The etiology mode of infection and specific therapy of Weil’s disease. J. Exp. Med., 23 : 377-402.

  • Inada, R. and Ido, Y. (1915). A report on the discovery of the causal organism (a new species of Spirochaeta) of Weil’s disease. Tokyo Ijishinshi, 1908 : 351-360.

  • Jena, A.B., Mohanty, K.C. and Devadasan, N. (2004). An outbreak of leptospirosis in Orissa, India: the importance of surveillance. Tropi. Med.& Internat. Health, 9 (9):1016-1021.

  • Kamath, S.A. and Joshi, S.R. (2003). Re-emerging infections in urban India – Focus Leptospirosis. J. Assoc. Phys. India, 51 : 247-248.

  • Karande, S., Bhatt, M., Kelkar, A., Kulkarni, M., De, A. and Varaiya, A. (2003). An observational study to detect leptospirosis in Mumbai, India, 2000. Archiv. Disease Childhood, 88 (12) : 1070-1075.

  • Karande, S., Kulkarni, H., Kulkarni, M., De, A. and Varaiya A. (2002). Leptospirosis in children in Mumbai slums. Indian J. Pediatric, 69 : 855-858.

  • Kmety, E. and Dicken, H. (1988). Revised list of “Leptospira” serovars. I Alphebetical order, II chronological order, 1 and 2 (Griningen, the Netherlands: University Press).

  • Kmety, E. and Dicken, H. (1993). Classification of the species Leptospira interrogans and history of its serovars (Griningen, The Netherlands: University Press).

  • Kuriakose, M., Eapen, C.K. and Paul, R. (1997). Leptospirosis in Kolenchery, Kerala, India. Epidemiology, Prevalent local serogroups and serovars and a new serovar. European J. Epidemiol., 13 (6) : 691-697.

  • Lahiri, M.N. (1941). A note on the occurrence of Leptospirosis in Bombay. Indian Med. Gaz., 76 : 669-670.

  • “Leptospirosis”. (2014). NHS. 07/11/2012. Retrieved 14 March 2014.

  • Manocha, H., Ghoshal, U., Singh, S.K., Kishore, J. and Ayyagari, A. (2004). Frequency of leptospirosis in patients of acute febrile illness in Uttar Pradesh. J. Assoc. Phys. India, 52 : 623-625.

  • McBride, A.J., Athanazio, D.A., Reis, M.G. and Ko, A.I. (2005). “Leptospirosis”: Curr. Opin. Infect. Diseas., 18 (5): 376–386.

  • Meites, E., Jay, M.T., Deresinski, S., Shieh, Wun-Ju., Zaki, S.R., Tompkins, L. and Smith, D.S. (2004). Reemerging Leptospirosis, California; Emerg. Infect. Dis., 10 : 406–412.

  • Mosby’s Medical Dictionary (2013). Elsevier Health Sciences. 9th Ed. p. 697. ISBN 9780323112581.

  • Noguchi, H. (1928). The spirochaetes, in the newer knowledge of bacteriology and immunology, Jordan EO and Falk IS. University of Chicago Press, Chicago, 452-497pp.

  • Patel, B.K., Gandhi, S.J. and Desai, D.C. (2006). Clinicoepidemiological aspects of leptospirosis in south Gujarat. Indian J. Med. Microbiol., 24 (4) : 322-326.

  • Rao, R.S., Gupta, N., Bhalla, P. and Agarwal S.K. (2003). Leptospirosis in India and the Rest of the World. Brazilian J. Infect. Diseas., 7 (3) : 178-193.

  • Ratnam, S., Sundararaj, T., Thyagarajan, S.P., Rao, R.S.and Madanagopalan, N. (1983).Serological evidence of leptospirosis in Jaundice and Pyrexia of unknown origin. Indian J. Med. Res., 77 : 427-430.

  • Ratnam, S., Suramaniam, S. and Madanagopalan, T. (1983). Isolation of leptospirosis and demonstration of antibodies in Human leptospirosis in Madras, India. Trans. R Soc. Trop. Med. Hyg., 77:455-458.

  • Report of the Brainstorming meeting on Leptospirosis Prevention and control Mumbai,1617February, 2006. Joint Publication by Office of WHO, Representative to India, New Delhi and Regional Medical Research Centre (ICMR), WHO Collaborating Centre for Diagnosis, Research, Reference and Training in Leptospirosis, Port Blair, Andaman and Nicobar Islands.

  • Sanford, J.P. (1994). Leptospirosis. In: Isselbacher, K.J., Braunwald, E., Wilson, J.D., Martin, J.B., Fauci, A.S. and Kasper, D.L. (eds). Harrison’s principles of internal medicine. Vol. 1. 13th Ed. New York : Mc Graw Hill, 740– 743pp.

  • Sehgal, S.C. (1998). Emergence of leptospirosis as a public health problem. Proceedings of the third round table conference. Series- leptospirosis. Ranbaxy Sci. Foundation, 3 : 7-12.

  • Sehgal, S.C., Sugunan, A.P., Murhekar, M.V., Sharma, S. and Vijayachari, P. (2000). Randomised controlled trial of doxycykline prophylaxis in an endemic area. Internat. J. Antimicrob. Agents, 13: 249-255.

  • Sehgal, S.C., Sugunan, A. P. and Vijayalakshmi, P. (2002). Outbreak of leptospirosis after the cyclone in Orissa. Nat. Med. J. India, 15: 22-23.

  • Shivakumar, S. (2008). Leptospirosis - Current Scenario in India. Med. Update, 18 : 799 – 809.

  • Singh, S.S., Vijayachari, P., Sinha, A. and Sugunan, A.P. (1999). Clinical- epidemiological study of hospitalized cases of severe leptospirosis. Indian J. Med. Res., 109 : 94-99.

  • Stimson, A. M. (1907). Note on an organism found in yellow fever tissue. Publ. Hlth. Rep., 22:541.

  • Taylor, J. and Goyle, A.N. (1931). Leptospirosis in the Andaman. Indian Med. Res. Memoirs, 20 : 55–56.

  • Terepstra et al. (2003). Human Leptospirosis: Guidelines for Diagnosis, Surveillance & Control WHO, 1-109 pp.

  • Thangluah, L. (2009). Effectiveness of a video assisted teaching programme on knowledge regarding leptospirosis among farmers in selected rural areas, Bangalore (KARNATAKA) INDIA.

  • Uhlenhuth, P. and Formme, W. (1916). Quoted in Topley and Wilson’s Principles of Bacteriology, Virology & Immunit. 8 (2) : 617.

  • Vijayachari, P., Sugunan, A. P. and Shriram, A. N. (2008). Leptospirosis: an emerging global public health problem. J. Biosci., 33 :557–569.

  • WHO (2003). Human Leptospirosis: guidance for diagnosis, surveillance and control. pp.1-24.

  • World Health Organization (2006). Report of the Brainstorming Meeting on Leptospirosis Prevention and Control. Mumbai, 16 – 17 February 2006, WHO India and Regional Medical Research Centre, WHO Collaborating Centre for Diagnosis, Research, Reference and Training in Leptospirosis.

  • WHO (2009). Global Burden of Human Leptospirosis: by the Leptospirosis Burden Epidemiology Reference Group (LERG).

  • Zaki, S. R. and Sheih, W. J. (1995). Leptospirosis associated with outbreak of acute febrile illness with pulmonary haemorrhage, Nicaragua. The epidemic working group at Ministry of health in Nicaragua. Lancet, 347 (9000): 535536.

  • http://timesofindia.indiatimes.com/city/mumbai/Lepto-scareinMumbai-12-patients die-in a week/articleshow/ 47980391.cms.

  • http://www.who.int/zoonoses/diseases/Lerg_brochure.pdf.

  • https://en.wikipedia.org/wiki/Leptospirosis.

  • ProMED archive:20110829.2647.

  • ProMED archive:20110925.2912.

  • ProMED archive:20110924.2886.

  • ProMED archive:29.1798872.

  • ProMED archive:20130625.1791771.

  • ProMED archive:20140623.2558792.

  • www.cdc.gov/leptospirosis.


Abstract Views: 344

PDF Views: 0




  • Leptospirosis:A Disease of Public Health Importance

Abstract Views: 344  |  PDF Views: 0

Authors

Vandana Gupta
Department of Foods and Nutrition, Ethelind School of Home Science, Sam Higginbottom Institute of Agriculture, Technology and Sciences, ALLAHABAD (U.P.), India
Neeru Bala
Department of Foods and Nutrition, Ethelind School of Home Science, Sam Higginbottom Institute of Agriculture, Technology and Sciences, ALLAHABAD (U.P.), India

Abstract


Leptospirosis has been recognized as an important emerging global public health problem because of its epidemic proportions and increasing incidence in both developing and developed countries. The disease is endemic in Kerala, Tamil Nadu, Gujarat, Andaman, Karnataka, Maharashtra. It has also been reported from Andhra Pradesh, Orissa, West Bengal, Uttar Pradesh, Delhi and Puducherry. It is an infectious disease caused by pathogenic bacteria called leptospires which has over 20 serogroups and more than 200 serovars. Man is infected either directly through contact with an infected animal or indirectly by water or soil contaminated with the urine of an infected animal. Human-to-human transmission occurs only very rarely. Leptospirosis can manifest in many ways. Clinical diagnosis is difficult because of the varied and non-specific presentation. In this situation, ELISA tests is particularly useful in making early diagnosis. Other serological tests available are indirect flouroscent antibody test (IFAT), indirect hemagglutination tests (IHAT), latex agglutination tests (LAT), micro capsule agglutination tests (MicAT), counter immuneelectrophoresis (CIE) and CFT etc. Antibiotic treatment is effective within 7 to 10 days of infection and it should be given immediately on diagnosis or suspicion. In severe cases, admission to a hospital is necessary. Identification of the potential risk factors would help understand the transmission dynamics of the disease and formulate public health interventions.

Keywords


Leptospirosis, Outbreak, Clinical Diagnosis, Risk Factors.

References